deltatrials
Completed NA NCT01901458

Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®

Prospective Randomized Trial Comparing Efficiency of Peripheral Blood Progenitor Cell Collection in Allogeneic Donors Using the Spectra Optia® IDL Set in Comparison With the Spectra Optia® MNC Collection Set

Sponsor: Chugai Pharma USA

Conditions Granulocyte Colony-stimulating Factor (G-CSF) Mobilized Healthy Allogeneic Donors
Interventions Spectra Optia® Collection Set Spectra Optia® IDL-Set
Updated 6 times since 2017 Last updated: Mar 18, 2015 Started: Mar 31, 2014 Primary completion: Nov 30, 2014 Completion: Nov 30, 2014

A NA clinical study on Granulocyte Colony-stimulating Factor (G-CSF) Mobilized and Healthy Allogeneic Donors, this trial is completed. The trial is conducted by Chugai Pharma USA and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chugai Pharma USA
  • Heinrich-Heine University, Duesseldorf
  • Terumo BCT
Data source: Heinrich-Heine University, Duesseldorf

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Cologne, Germany
  • • Düsseldorf, Germany